Acute Impact of the Impella CP Assist Device in Pts. With Cardiogenic Shock on the Patients Hemodynamic

JENA Mechanical Assist Circulatory Support Trial-JENAMACS-hemodynamic

Prospective, monocentric open-label observational study for the assessment of acute hemodynamic effects following implantation of the IMPELLA CP cardiac support device

Inclusion Criteria:

• Cardiogenic shock following acute MI or acute heart failure with

  • systolic BP < 90 mm Hg over > 30 min or inotropes for support of cardiac output and BP with
  • signs of left heart failure and pulmonary congestion
  • and end-organ hypo perfusion with somnolence or cold, pale skin, or oliguria or serum lactate >2 mmol/l

Exclusion Criteria: